AstraZeneca CEO Pascal Soriot shakes hands with U.S. President Donald Trump during an announcement about lowering U.S. drug prices, at the White House in Washington, D.C., U.S., October 10, 2025. REUTERS/Kent Nishimura
AstraZeneca CEO Pascal Soriot shakes hands with U.S. President Donald Trump during an announcement about lowering U.S. drug prices, at the White House in Washington, D.C., U.S., October 10, 2025. REUTERS/Kent Nishimura